Surf Wiki

Victoria Barracks is a British Army barracks located 0.25 miles (0.40 km) south of Windsor Castle.

Diphosphate—fructose-6-phosphate 1-phosphotransferase also known as PFP is an enzyme of carbohydrate metabolism in plants and some bacteria. The enzyme (EC 2.7.1.90) catalyses the reversible interconversion of fructose 6-phosphate and fructose 1,6-bisphosphate using inorganic pyrophosphate as the phosphoryl donor:

John Phillip Lipsky (born February 19, 1947) is an American economist. He was the acting managing director of the International Monetary Fund from May to July 2011. He assumed the post of acting managing director after Dominique Strauss-Kahn was arrested in May 2011 accused of sexual assault. After the appointment of Christine Lagarde he returned to his post as the first deputy managing director of the IMF. He retired from the IMF in November 2011 and is currently a distinguished visiting scholar at Johns Hopkins School of Advanced International Studies (SAIS).

Sclessin (French pronunciation: ) is a quarter of the city of Liège located in the province of Liège, Wallonia, Belgium. Before the fusion of the Belgian municipalities in 1977, it was a quarter of the municipality of Ougrée. On 1 January 1977, it was merged into Liège. Sclessin has never been a municipality, but in some sources, Sclessin is mentioned as a "section" (sub-municipality).

Oom-pah, Oompah, Ooumpah or Umpapa is an onomatopoeic term describing the rhythmic sound of a deep brass instrument in combination with the response of other instruments or registers in a band, a form of background ostinato.

Simon Raynard Fletcher (born February 18, 1962) is an American former professional football player who was a linebacker for the Denver Broncos of the National Football League (NFL). He played college football for the Houston Cougars. Fletcher was selected by the Broncos in the second round of the 1985 NFL draft.

The Hyperspectral Imager for the Coastal Ocean (HICO) was a hyperspectral earth observation sensor that operated on the International Space Station (ISS) from 2009 to 2014. HICO collected hyperspectral satellite imagery of the Earth's surface from the ISS.

The Hall of Transportation, Treasure Island, on Treasure Island, California, also known as Building 2, was built in 1938 for the 1939-40 Golden Gate International Exposition. It served as the hall of transportation for the exposition. It was constructed with the idea that it would serve as an airplane hangar after the Exposition but it never did. It was designed in Moderne style by architects William Peyton Day and George William Kelham. It was listed on the National Register of Historic Places in 2008.

Chittenango Creek is a small river in central New York, United States. The creek partially forms the boundary between Onondaga County and Madison County.

Sarat Chandra Sinha (1 January 1914 – 25 December 2005) was an Indian politician and Chief Minister of Assam. He was a leader of Indian National Congress, Indian National Congress (Socialist) and Nationalist Congress Party.

Uri Sebag (Hebrew: אורי סבג; born 11 November 1931) is an Israeli former politician who served as a member of the Knesset for the Alignment during the 1980s.

Levance E. Fields (born June 14, 1987) is an American professional basketball player. He played college basketball at the University of Pittsburgh.

Seneca Foods Corporation reported Net Income: $41.2M, EPS: $5.95 in FY 2025.

SEMTECH CORP reported Revenue: $1.0B, Net Income: -$40.4M in FY 2026.

SPX Technologies, Inc. reported Revenue: $2.3B, Net Income: $244.0M in FY 2025.

SEABOARD CORPORATION reported Net Income: $501.0M, EPS: $514.46 in FY 2025.

HORIZON KINETICS HOLDING CORPORATION reported Revenue: $72.8M, Net Income: $5.1M in FY 2025.

SCIENTIFIC INDUSTRIES, INC. reported Revenue: $5.1M, Net Income: -$1.2M in FY 2025.

SLB LIMITED/NV reported Net Income: $3.4B, EPS: $2.38 in FY 2025.

Neonode Inc. reported Net Income: $8.5M, EPS: $0.51 in FY 2025.

The Travelers Companies, Inc. reported Revenue: $48.8B, Net Income: $6.3B in FY 2025.

SAFEGUARD SCIENTIFICS INC reported EPS: $-0.27, Total Assets: $22.8M in FY 2023.

RYDER SYSTEM, INC. reported Revenue: $12.7B, Net Income: $499.0M in FY 2025.

Royal Gold, Inc. reported Revenue: $1.0B, Net Income: $466.3M in FY 2025.

You will rejoice to hear that no disaster has accompanied the commencement of an enterprise which you have regarded with such evil forebodings. I arrived here yesterday, and my first task is to assure my dear sister of my welfare and increasing confidence in the success

This text is a combination of etexts, one from the now-defunct ERIS project at Virginia Tech and one from Project Gutenberg’s archives. The proofreaders of this version are indebted to The University of Adelaide

Thatcher Overshadowed—Tom Becomes Jealous—Black Revenge

breast cancer susceptibility genes encode proteins, the normal cellular functions of which are complex and multiple, and germ-line mutations in individuals predispose both to breast and to ovarian cancer. There is nevertheless substantial evidence linking BRCA1 and BRCA2 to homologous recombination and DNA repair, to transcriptional control and to tissue proliferation. There is controversy regarding the localization of BRCA1 and BRCA2 proteins to either nucleus or cytoplasm and whether the expression is present in premeiotic germ cells or can still be expressed in mitotic spermatogonia. We report herein an immunohistochemical study of BRCA1 and BRCA2 distribution in a rather unsual tissue (an ovotestis), which addresses this issue.

Using semiquantitative reverse transcription-polymerase chain reaction assays, we investigated the expression of variant messenger RNAs relative to wild-type estrogen receptor (ER)-α messenger RNA in normal breast tissues and their adjacent matched breast tumor tissues. Higher ER variant truncated after sequences encoding exon 2 of the wild-type ER-α (ERC4) messenger RNA and a lower exon 3 deleted ER-α variant (ERD3) messenger RNA relative expression in the tumor compartment were observed in the ER-positive/PR-positive and the ER-positive subsets, respectively. A significantly higher relative expression of exon 5 deleted ER-α varient (ERD5) messenger RNA was observed in tumor components overall. These data demonstrate that changes in the relative expression of ER-α variant messenger RNAs occur between adjacent normal and neoplastic breast tissues. We suggest that these changes might be involved in the mechanisms that underlie breast tumorigenesis. Estrogen receptor (ER)-α and ER-β are believed to mediate the action of estradiol in target tissues. Several ER-α and ER-β variant messenger RNAs have been identified in both normal and neoplastic human tissues. Most of these variants contain a deletion of one or more exons of the wild-type (WT) ER messenger RNAs. The putative proteins that are encoded by these variant messenger RNAs would therefore be missing some functional domains of the WT receptors, and might interfere with WT-ER signaling pathways. The detection of ER-α variants in both normal and neoplastic human breast tissues raised the question of their possible role in breast tumorigenesis. We have previously reported an increased relative expression of exon 5 deleted ER-α variant (ERD5) messenger RNA and of another ER-α variant truncated of all sequences following the exon 2 of the WT ER-α (ERC4) messenger RNA in breast tumor samples versus independent normal breast tissues. In contrast, a decreased relative expression of exon 3 deleted ER-α variant (ERD3) messenger RNA in tumor tissues and cancer cell lines versus independent normal reduction mammoplasty samples has recently been reported. These data were obtained in tissues from different individuals and possible interindividual differences cannot be excluded. The goal of this study was to investigate the expressions of ERC4, ERD5 and ERD3 variant messenger RNAs in normal breast tissues and their matched adjacent primary breast tumor tissues. Eighteen cases were selected from the Manitoba Breast Tumor Bank, which had well separated and histopathologically characterized normal and adjacent neoplastic components. All tumors were classified as primary invasive ductal carcinomas. Six tumors were ER-negative/progesterone receptor (PR)-negative, nine were ER-positive/PR-positive, two were ER-positive/PR-negative, and one was ER-negative/PR-positive, as measured by ligand-binding assay. For each specimen, total RNA was extracted from frozen normal and tumor tissue sections and was reverse transcribed. The expressions of ERC4, ERD3 and ERD5 messenger RNAs relative to WT ER-α messenger RNA were investigated by previously validated semiquantitative reverse transcription polymerase chain reaction (PCR) assays performed using three different sets of primers. = 0.019, Wilcoxon signed-rank test). ). =0.035, Wilcoxon signed-rank test). A statistically significant higher ERC4 messenger RNA expression was found in ER-positive/PR-positive tumors as compared with matched normal breast tissues. ERC4 variant messenger RNA has previously been demonstrated to be more highly expressed in ER-positive tumors that showed poor as opposed to tumors that showed good prognostic characteristics. Interestingly, we also have reported similar levels of expression of ERC4 messenger RNA in primary breast tumors and their concurrent axillary lymph node metastases. Taken together, these data suggest that the putative role of the ERC4 variant might be important at different phases of breast tumorigenesis and tumor progression; alteration of ERC4 messenger RNA expression and resulting modifications in ER signaling pathway probably occur before breast cancer cells acquire the ability to metastasize. Transient expression assays revealed that the protein encoded by ERC4 messenger RNA was unable to activate the transcription of an estrogen-responsive element-reporter gene or to modulate the wild-type ER protein activity. The biologic significance of the changes observed in ERC4 messenger RNA expression during breast tumorigenesis remains to be determined. , who showed a decreased relative expression of ERD3 messenger RNA in neoplastic breast tissues compared with independent reduction mammoplasty and breast tumor. Transfection experiments showed that the activation of the transcription of the pS2 gene by estrogen was drastically reduced in the presence of increased ERD3 expression. The authors hypothesized that the reduction in ERD3 expression could be a prerequisite for breast carcinogenesis to proceed. We observed a significantly higher relative expression of ERD5 messenger RNA in breast tumor components compared with matched adjacent normal breast tissue. These data confirm our previous observations performed on unmatched normal and neoplastic human breast tissues. Upregulated expression of this variant has already been reported in ER-negative/PR-positive tumors, as compared with ER-positive/PR-positive tumors, suggesting a possible correlation between ERD5 messenger RNA expression and breast tumor progression. Even though it has been suggested that ERD5 could be related to the acquisition of insensitivity to antiestrogen treatment (ie tamoxifen), accumulating data refute a general role for ERD5 in hormone-resistant tumors. Only ER-positive pS2-positive tamoxifen-resistant tumors have been shown to express significantly higher levels of ERD5 messenger RNA, as compared with control tumors. Taken together, these data suggest that the exact biologic significance of ERD5 variant expression during breast tumorigenesis and breast cancer progression, if any, remains unclear. In conclusion, we have shown that the relative expressions of ERC4 and ERD5 variant messenger RNAs were increased in human breast tumor tissue, as compared with normal adjacent tissue, whereas the expression of ERD3 variant messenger RNA was decreased in breast tumor tissues. These results suggest that the expressions of several ER-α variant messenger RNAs are deregulated during human breast tumorigenesis. Further studies are needed to determine whether these changes are transposed at the protein level. Furthermore, the putative role of ER-α variants in the mechanisms that underlie breast tumorigenesis remains to be determined.

Current smoking was strongly and inversely associated with high-risk patterns, after adjustment for concomitant risk factors. Relative to never smokers, current smokers were significantly less likely to have a high-risk pattern. Similar results were obtained when the analysis was confined to postmenopausal women. Past smoking was not related to the mammographic parenchymal patterns. The overall effect in postmenopausal women lost its significance when adjusted for other risk factors for P2/DY patterns that were found to be significant in the present study, although the results are still strongly suggestive. The present data indicate that adjustment for current smoking status is important when evaluating the relationship between mammographic parenchymal pattern and breast cancer risk. They also indicate that smoking is a prominent potential confounder when analyzing effects of other risk factors such as obesity-related variables. It appears that parenchymal patterns may act as an informative biomarker of the effect of cigarette smoking on breast cancer risk. ]. There are no published studies that assessed the relationship between smoking and mammographic parenchymal patterns. ], the association between smoking habits and mammographic parenchymal patterns are examined. The full results will be published elsewhere. Study subjects were members of the EPIC cohort in Norwich who also attended the prevalence screening round at the Norwich Breast Screening Centre between November 1989 and December 1997, and were free of breast cancer at that screening. Cases were defined as women with a P2/DY Wolfe's mammographic parenchymal pattern on the prevalence screen mammograms. A total of 203 women with P2/DY patterns were identified as cases and were individually matched by date of birth (within 1 year) and date of prevalence screening (within 3 months) with 203 women with N1/P1 patterns who served as control individuals. Two views, the mediolateral and craniocaudal mammograms, of both breasts were independently reviewed by two of the authors (ES and RW) to determine the Wolfe mammographic parenchymal pattern. ]. In the present study we examined the subjects' personal history of benign breast diseases, menstrual and reproductive factors, oral contraception and hormone replacement therapy, smoking, and anthropometric information such as body mass index and waist:hip ratio. ], and were adjusted for possible confounding factors. . Cases were leaner than controls. A larger percentage of cases were nulliparous, premenopausal, current hormone replacement therapy users, had a personal history of benign breast diseases, and had had a hysterectomy. A larger proportion of controls had more than three births and were current smokers. shows the unadjusted and adjusted OR estimates for Wolfe's high-risk mammographic parenchymal patterns and smoking in the total study population and in postmenopausal women separately. Current smoking was strongly and inversely associated with high-risk patterns, after adjustment for concomitant risk factors. Relative to never smokers, current smokers were significantly less likely to have a high-risk pattern (OR 0.37, 95% CI 0.14-0.94). Similar results were obtained when the analysis was confined to postmenopausal women. Past smoking was not related to mammographic parenchymal patterns. The overall effect in postmenopausal women lost its significance when adjusted for other risk factors for P2/DY patterns that were found to be significant in the present study, although the results were still strongly suggestive. There was no interaction between cigarette smoking and body mass index. ] found a reduced risk of breast density in association with smoking, although the magnitude of the reduction was unclear. The present findings suggest that this reduction is large. ], who reported that breast cancer risk in younger women (younger than 45 years) may be reduced among current smokers who began smoking at an early age (OR 0.59, 95% CI 0.41-0.85 for age 15 years or younger) and among long-term smokers (OR 0.70, 95% CI 0.52-0.94 for those who had smoked for 21 years or more). ], however, do not support these findings. ]. The present data indicate that adjustment for current smoking status is important when evaluating the relationship between mammographic parenchymal pattern and breast cancer risk. They also indicate smoking as a prominent potential confounder when analyzing effects of other risk factors such as obesity-related variables. It seems that parenchymal patterns may act as an informative biomarker of the effect of cigarette smoking on breast cancer risk.

. Despite demonstrable chemopreventive efficacy in this model, none of these agents, alone or in combination, had any significant impact on the expression of TGF-βs in the mammary ductal epithelium or periductal stroma as determined by immunohistochemistry. These data suggest that TGF-βs are not likely to be useful biomarkers of chemopreventive efficacy in a clinical setting.

Seneca Foods Corporation reported Net Income: $41.2M, EPS: $5.95 in FY 2025.

ALEXANDERS INC reported Revenue: $213.2M, Net Income: $28.2M in FY 2025.

ALICO, INC. reported Net Income: -$147.3M, EPS: $-19.29 in FY 2025.

CECO ENVIRONMENTAL CORP. reported Revenue: $774.4M, Net Income: $50.1M in FY 2025.